ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,828 | -0.8% | 42 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,851 | +25.1% | 42 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,279 | -9.5% | 42 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,518 | +25.9% | 42 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 42 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | 0.0% | 42 | -8.7% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -25.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | 0.0% | 46 | -22.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | 0.0% | 59 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | 0.0% | 59 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $4,000 | -20.0% | 59 | -29.8% | 0.00% | -50.0% |
| Q4 2018 | $5,000 | – | 84 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |